Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:TG 62:2)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST004095 AN006788 Hep3B PNPLA3 wild type and PNPLA3(I148M) lipidomics Cultured cells Human Cancer Amgen LC-MS
ST003522 AN005784 Untargeted mass spectrometry analysis of neutral lipids in MC38 tumors and visceral adipose tissues of control-diet and high fat diet-fed C57BL/6 mice Adipose tissue Mouse Cancer Stanford University LC-MS
ST003522 AN005784 Untargeted mass spectrometry analysis of neutral lipids in MC38 tumors and visceral adipose tissues of control-diet and high fat diet-fed C57BL/6 mice Tumor tissue Mouse Cancer Stanford University LC-MS
ST003293 AN005392 High Fat Feeding Alters Circulating Triglyceride Profile by Decreasing SCD Activity and Depleting omega-3 Fatty Acids Blood Rat Hyperlipidemia University of Southern California LC-MS
ST003220 AN005280 Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue Adipose tissue Mouse Obesity University of Utah LC-MS
ST003157 AN005179 Diet modulates the protective effects of dimethyl fumarate mediated by the immunometabolic neutrophil receptor HCA2 - Lipidomics Blood Mouse Multiple sclerosis University of Luebeck LC-MS
ST003090 AN005054 Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B Cultured cells Mouse Rutgers University LC-MS
ST003051 AN005002 Shotgun lipidomics of breast cancer endocrine therapy persisters Breast cancer cells Human Cancer Dartmouth College LC-MS
ST002843 AN004653 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) Liver Mouse Cancer Rutgers University LC-MS
ST002842 AN004651 Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) Liver Mouse Cancer Rutgers University LC-MS
ST002817 AN004584 Investigation of metabolism in hypertrophic cardiomyopathy - Lipidomics Heart Mouse Cardiomyopathy University of California, San Francisco LC-MS
ST002764 AN004499 Identification of pre-diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis – a nested case-control study within the ATBC cohort Blood Human Cancer Icahn School of Medicine at Mount Sinai LC-MS
ST002729 AN004426 Improved Endurance Capacity of Diabetic Mice during SGLT2 Inhibition: Potential Role of AICARP, an Endogenous AMPK Activator. Muscle Mouse Diabetes Medical Institute of Bioregulation, Kyushu University LC-MS
ST002700 AN004376 Metabolomic analysis of maternal mid-gestation plasma and cord blood: lipidomics Blood Human Autism Columbia University LC-MS
ST002438 AN003972 Ozone alters glycosphingolipid metabolism and exacerbates characteristics of asthma in mice Lung Mouse Asthma University of California, Davis LC-MS
ST002422 AN003944 UBXD8 lipidomics from whole cells (Part 2) Cultured cells Human University of Arizona LC-MS
ST002421 AN003942 UBXD8 lipidomics from whole cells (Part 1) Cultured cells Human University of Arizona LC-MS
ST002409 AN003926 Spatial, temporal, and inter-subject variation of the metabolome along the human upper intestinal tract (MS RP positive data) Intestine Human University of California, Davis LC-MS
ST002070 AN003374 Lipidomic Comparison of 2D and 3D Colon Cancer Cell Culture Models Cultured cells Human Cancer Ohio State University LC-MS
ST002057 AN003349 Distinct Human Hepatocyte Lipidomics Profiles for Nonalcoholic Steatohepatitis and In Vitro-Induced Steatosis Cultured cells Human NASH Monash Institute of Pharmaceutical Sciences LC-MS
ST002002 AN003265 A case-control study on plasma metabolomics analysis in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (Part 3) Blood Human Myalgic encephalomyelitis/chronic fatigue syndrome Columbia University LC-MS
ST001989 AN003241 THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 3) LNCaP cells Human Cancer IGMM LC-MS
ST001988 AN003240 THEM6-mediated lipid remodelling sustains stress resistance in cancer (Part 2) LNCaP cells Human Cancer IGMM LC-MS
ST001950 AN003174 Lipidome Alterations Following Mild Traumatic Brain Injury. Blood Rat Traumatic brain injury Georgia Institute of Technology LC-MS
ST001949 AN003173 Plasma Metabolome Normalization in Rheumatoid Arthritis following initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy Blood Human Rheumatoid arthritis University of Kansas GC-MS
ST001843 AN002986 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) Blood Human Fatty liver disease University of California, Davis GC-MS
ST001843 AN002986 Identification of unique metabolite networks between Latino and Caucasian patients with nonalcoholic fatty liver disease (NAFLD) (part II) Liver Human Fatty liver disease University of California, Davis GC-MS
ST001815 AN002946 Metabolic Markers of Methotrexate Response in Juvenile Idiopathic Arthritis Blood Human Arthritis University of Kansas GC-MS/LC-MS
ST001451 AN002426 Eleostearic acid effects on TAGs and oxLipids Breast cancer cells Human Cancer Fox Chase Cancer Center LC-MS
ST001363 AN002269 Monophasic lipidomics extraction in cancer cell lines Hep G2 cells Human Cancer Institute of Genetics and Molecular Medicine LC-MS
ST001292 AN002149 Metabolomics of blood plasma and kidney tissue from control (db/m) and diabetic (db/db) mice. Kidney Mouse Diabetes University of Michigan LC-MS
ST001211 AN002018 Metabolomic Markers of Methotrexate Response, In Vitro Cultured cells Human University of Kansas GC-MS/LC-MS
ST000991 AN001617 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) Blood Human University of California, Davis LC-MS
ST000990 AN001616 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) Blood Human University of California, Davis LC-MS
ST000989 AN001615 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) Blood Human University of California, Davis LC-MS
ST000988 AN001614 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) Blood Human University of California, Davis LC-MS
ST000987 AN001613 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) Blood Human University of California, Davis LC-MS
ST000985 AN001611 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) Blood Human University of California, Davis LC-MS
ST000984 AN001610 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) Blood Human University of California, Davis LC-MS
ST000983 AN001609 Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) Blood Human University of California, Davis LC-MS
ST000781 AN001237 Rabbit Plasma Lipidomics with high fat diet and treatment Blood Rabbit University of Michigan LC-MS
ST000780 AN001235 High fat diet and sciatic nerves functions Blood Mouse Neuropathy University of Michigan LC-MS
ST000778 AN001231 Rat Colon Study effect of Effect of fish oil on azoxymethane (AOM) Colon Rat University of Michigan LC-MS
ST000775 AN001225 Michigan Biomarkers for Refractory Depression (Bluebird) metabolomics pilot study Blood Human Depression University of Michigan LC-MS
ST000763 AN001204 Untargeted metabolomics and lipidomics of scleroderma PAH discovery cohort Blood Human Scleroderma University of Michigan LC-MS
ST000695 AN001078 Pilot metabolomics study of aromatase inhibitor associated arthralgias Blood Human Arthralgia University of Michigan LC-MS
ST000688 AN001062 Biomarkers for different types of Multiple Scelerosis (MS) (BMS vs SPMS lipidomics) Unspecified Human Multiple sclerosis University of Michigan LC-MS
ST000670 AN001027 Exposure to high fat diets and bisphenol Blood Mouse University of Michigan LC-MS
ST000669 AN001025 Characterization of Retinal Exudates in Coats Disease - lipid profile Eye tissue Human Eye disease University of Michigan LC-MS
ST000668 AN001023 Diet manipulation on the lipidome Blood Human University of Michigan LC-MS
ST000665 AN001017 Nonalcoholic fatty liver disease (NAFLD) Studies Cultured cells Human Fatty liver disease University of Michigan LC-MS
ST000664 AN001015 Nutritional Psychiatric Illness Studies Blood Human Bipolar I Disorder University of Michigan LC-MS
ST000662 AN001011 Lipidomics of hormone-sensitive lipase variants Adipose tissue Human University of Michigan LC-MS
ST000661 AN001009 CHOICE clinical weight loss study Blood Human Obesity University of Michigan LC-MS
ST000661 AN001009 CHOICE clinical weight loss study Blood Rat Obesity University of Michigan LC-MS
ST000148 AN000235 A549 13C-labeled Cell Study Epithelial cells Human Cancer University of Kentucky LC-MS
ST000110 AN000183 SIRM Analysis of human P493 cells under hypoxia in [U-13C/15N] labeled Glutamine medium (Both positive and ion mode FTMS) B-cells Human University of Kentucky GC-MS/LC-MS
ST000089 AN000141 A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis Ovarian cancer cells Human Cancer University of California, Davis LC-MS
ST000089 AN000142 A study of changes in lipid metabolism of ovarian cancer cells co-cultured with adipocytes: UHPLC-QTOF MS analysis Ovarian cancer cells Human Cancer University of California, Davis LC-MS
ST000081 AN000131 Metabolic Profiling of Visceral and Subcutaneous Adipose Tissue from Colorectal Cancer Patients: UHPLC-QTOF MS analyis of subcutaneous and visceral adipose tissue samples Adipose tissue Human Cancer University of California, Davis LC-MS
  logo